Exiqon A/S Press release Exiqon and Takara Bio Inc. partner on the distribution of miRCURY LNA products in Asia

Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression analysis products, today announced that Takara Bio Inc. will take over the distribution of miRCURY LNA products in Asia.

Takara Bio Inc. will market Exiqons life sciences products in Japan, China, Hong Kong, South Korea and India.

Takara Bio Inc. is a leading provider and distributor of life science research products in Asia.

We are pleased to announce that Takara Bio will distribute Exiqons products in the important growth markets of India and East Asia, said Senior Vice President Sales & Marketing Exiqon, Henrik M. Pfundheller and added: The interest for microRNA research and our miRCURY LNA product lines continues to grow rapidly throughout the world, and Asia is an important growth market where we expect customers will benefit from our combined efforts with Takara Bio to meet customer demand for high quality research products.

Takara Bio Inc. will initiate the distribution of Exiqons products in January 2013 but will launch research services using Exiqons products in December 2012.

Takara Bio Inc. joins Exiqons network of distributors covering Central and Southern Europe, the Middle East, Brazil, Asia, Australia and New Zealand.

Additional information Henrik M. Pfundheller, SVP Sales & Marketing, tel. +45 4565 0420 (cell: +45 4090 2106) Lars Kongsbak, President and CEO, tel. +45 4566 0888 (cell: +45 4090 2101)

 

About Karl M. Bidstrup

Tidligere ejer af Medicoinvestor.com Strategien har gennem mange år været at profitere på etablerede aktier, og brænde det hele af på Bioporto... Sad but true. Kontakt mig på medicoinvestor(A)gmail.com hvis du har en million du ikke ved hvor du skal gemme, så skal jeg nok holde den for dig. :-)

 

What do you say?

Set your Twitter account name in your settings to use the TwitterBar Section.